New York Post
@nypost·2.4M subscribers·43.2K videos
MDMA expected to be approved to treat PTSD by October: study | New York Post
Posted
April 21, 2023
Views
746
Likes
20
Comments
16
Engagement
4.83%
April 21, 2023
746
20
16
4.83%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
0:31Now PlayingThe US Food and Drug Administration will be asked to approve MDMA to treat post-traumatic stress disorder by October — opening the door to the use of hallucinogenic drugs to treat mental illness.
If approved, the drug will be available in hospitals before the second half of next year, according to new research.
MDMA, also known as ecstasy or molly, is a popular drug in rave culture, with people taking it to connect with the music and dance the night away.
However, a 2021 clinical trial for the nonprofit organization Multidisciplinary Association for Psychedelic Studies showed that out of 90 people who suffered from post-traumatic stress disorder, those who took MDMA paired with psychotherapy were twice as likely to recover compared to those who did psychotherapy with a placebo, according to the journal Nature.
Read more at
#fda #mdma #ptsd
The New York Post is your source for breaking news, news about New York, sports, business, entertainment, opinion, real estate, culture, fashion, and more.
Subscribe to New York Post Sports
Catch the latest news here
Follow The New York Post on:
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
